OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL

Drug identity checked against registry records

Also recorded as DexNP

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
OCS-01 in Treating Inflammation and Pain in Post-cataract PatientsNCT04130802OculisPhase 2Completed2020-01-31Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.